Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Scientists drill down to genetic root of prostate tumour development
Research from an international collaboration of scientists has revealed new clues to the genetic causes of prostate cancer that has spread to other parts of the body.
Consortium signs deal with Basilea to develop resistance-busting cancer drugs
The cross-institution agreement with Basilea Pharmaceutica Ltd. will progress a new family of cancer drugs designed to tackle drug-resistant cancers.
Professor Paul Workman to co-host ‘Horizons in Cancer Drug Discovery’
Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, is to co-host ‘Horizons in Cancer Drug Discovery’ – a meeting of minds of academia, the pharmaceutical industry and investors to discuss innovative methods of cancer drug discovery.
New role uncovered for ‘oldest’ tumour suppressor gene
A new function has been found for one of the first cancer genes ever discovered.
Using multiple imaging measures could improve prostate cancer diagnosis
Combining a variety of different imaging parameters could be more accurate at diagnosing prostate cancer than an experienced radiologist.
Detecting cancer cells in blood can give an early warning of treatment failure
A blood test that measures the number of cells shed from prostate tumours into the bloodstream can act as an early warning sign that treatment is not working, a major new study shows.
Sperm and egg gene implicated in breast cancer
A gene normally used in the development of sperm and egg cells has been shown to be active in some types of breast cancer, suggesting new treatments might be available.
World-first cancer drugs could work in larger group of patients
A pioneering class of drugs that target cancers with mutations in the BRCA breast cancer genes could also work against tumours with another type of genetic fault, a new study suggests.
Discovery Club members supporting the next generation of cancer researchers
Members of The Discovery Club at The Institute of Cancer Research, London, met with PhD students last month to learn how they hope their research will transform the lives of cancer patients in the future.
Physics: unlocking the mysteries of tumours
Research into ionising radiation takes us from the edges of the universe to treatment planning for cancer
3D drug design leads to potent new drug candidate
ICR scientists have used structure-based drug design to identify a chemical probe that fits proteins implicated in some cancers like a 3D jigsaw puzzle.
New scan ‘feels’ stiffness or stretchiness of tumours
A new type of scan that measures the stiffness or stretchiness of tissues could help to diagnose different types of brain cancer, a new study reports.